---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-25-008618"
form_type: "8-K"
ticker: "ACTU"
cik: "0001652935"
company_name: "ACTUATE THERAPEUTICS, INC."
filed_at: "2025-11-21T23:59:59+00:00"
generated_at: "2026-05-16T17:38:22.927425+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.0
calibrated_materiality_score: 0.0
confidence: "low"
source: SEC EDGAR
---

# Actuate Therapeutics lists official disclosure channels including social media

## Summary
- Company announced it will use website, press releases, SEC filings, and social media for material information.
- Social media channels include X (@ActuateThera), LinkedIn, and Facebook.
- Investors can subscribe to press releases and SEC filings on the company's investor relations page.
- List may be updated from time to time; no other material news disclosed.

## SEC filing metadata
- accession: 0001683168-25-008618
- form_type: 8-K
- ticker: ACTU
- cik: 0001652935
- company_name: ACTUATE THERAPEUTICS, INC.
- filed_at: 2025-11-21T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.0
- calibrated_materiality_score: 0.0
- confidence: low
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1652935/000168316825008618/0001683168-25-008618-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1652935/000168316825008618/actuate_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-25-008618
- JSON: https://secwatch.observer/filing/0001683168-25-008618.json
- Plain text: https://secwatch.observer/filing/0001683168-25-008618.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.